N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine

C71H74F7N21O3 — CID 161307572

IUPACN-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine
SMILESCc1cc(C)n2nc(CC(=O)N(Cc3ccc(F)cc3)C3CC3)nc2n1.Cc1cc(C)n2nc(CC(=O)N(Cc3ccccc3F)C3CC3)nc2n1.Cc1cc(C2CCCN2c2cc(C(C)(F)F)nc3ncnn23)no1.Cc1cc(N2CCN(c3cccc(C(F)(F)F)c3)CC2)n2ncnc2c1
InChIInChI=1S/2C19H20FN5O.C18H18F3N5.C15H16F2N6O/c1-12-9-13(2)25-19(21-12)22-17(23-25)10-18(26)24(16-7-8-16)11-14-3-5-15(20)6-4-14;1-12-9-13(2)25-19(21-12)22-17(23-25)10-18(26)24(15-7-8-15)11-14-5-3-4-6-16(14)20;1-13-9-16-22-12-23-26(16)17(10-13)25-7-5-24(6-8-25)15-4-2-3-14(11-15)18(19,20)21;1-9-6-10(21-24-9)11-4-3-5-22(11)13-7-12(15(2,16)17)20-14-18-8-19-23(13)14/h3-6,9,16H,7-8,10-11H2,1-2H3;3-6,9,15H,7-8,10-11H2,1-2H3;2-4,9-12H,5-8H2,1H3;6-8,11H,3-5H2,1-2H3
InChIKeyVILPMNFSMLMMMQ-UHFFFAOYSA-N
MW1402.50 g/mol
LogP11.48
Rot. Bonds15

About N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine

N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine (PubChem CID 161307572) has the molecular formula C71H74F7N21O3 and a molecular weight of 1402.50 g/mol. Its IUPAC name is N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine.

Molecular Properties

Compound NameN-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine
PubChem CID161307572
Molecular FormulaC71H74F7N21O3
Molecular Weight1402.50 g/mol
Exact Mass1401.62
IUPAC NameN-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine
SMILESCc1cc(C)n2nc(CC(=O)N(Cc3ccc(F)cc3)C3CC3)nc2n1.Cc1cc(C)n2nc(CC(=O)N(Cc3ccccc3F)C3CC3)nc2n1.Cc1cc(C2CCCN2c2cc(C(C)(F)F)nc3ncnn23)no1.Cc1cc(N2CCN(c3cccc(C(F)(F)F)c3)CC2)n2ncnc2c1
InChIInChI=1S/2C19H20FN5O.C18H18F3N5.C15H16F2N6O/c1-12-9-13(2)25-19(21-12)22-17(23-25)10-18(26)24(16-7-8-16)11-14-3-5-15(20)6-4-14;1-12-9-13(2)25-19(21-12)22-17(23-25)10-18(26)24(15-7-8-15)11-14-5-3-4-6-16(14)20;1-13-9-16-22-12-23-26(16)17(10-13)25-7-5-24(6-8-25)15-4-2-3-14(11-15)18(19,20)21;1-9-6-10(21-24-9)11-4-3-5-22(11)13-7-12(15(2,16)17)20-14-18-8-19-23(13)14/h3-6,9,16H,7-8,10-11H2,1-2H3;3-6,9,15H,7-8,10-11H2,1-2H3;2-4,9-12H,5-8H2,1H3;6-8,11H,3-5H2,1-2H3
InChIKeyVILPMNFSMLMMMQ-UHFFFAOYSA-N
XLogP11.48
TPSA235.80 Ų
H-Bond Donors
H-Bond Acceptors22
Rotatable Bonds15
Heavy Atoms102
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001402.50
LogP ≤ 511.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1022

Analyze N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine?
The IUPAC name of N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine (CID 161307572) is N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine.
What is the SMILES notation for N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine?
The canonical SMILES for N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine is Cc1cc(C)n2nc(CC(=O)N(Cc3ccc(F)cc3)C3CC3)nc2n1.Cc1cc(C)n2nc(CC(=O)N(Cc3ccccc3F)C3CC3)nc2n1.Cc1cc(C2CCCN2c2cc(C(C)(F)F)nc3ncnn23)no1.Cc1cc(N2CCN(c3cccc(C(F)(F)F)c3)CC2)n2ncnc2c1.
What is the InChIKey of N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine?
The InChIKey is VILPMNFSMLMMMQ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H20FN5O.C18H18F3N5.C15H16F2N6O/c1-12-9-13(2)25-19(21-12)22-17(23-25)10-18(26)24(16-7-8-16)11-14-3-5-15(20)6-4-14;1-12-9-13(2)25-19(21-12)22-17(23-25)10-18(26)24(15-7-8-15)11-14-5-3-4-6-16(14)20;1-13-9-16-22-12-23-26(16)17(10-13)25-7-5-24(6-8-25)15-4-2-3-14(11-15)18(19,20)21;1-9-6-10(21-24-9)11-4-3-5-22(11)13-7-12(15(2,16)17)20-14-18-8-19-23(13)14/h3-6,9,16H,7-8,10-11H2,1-2H3;3-6,9,15H,7-8,10-11H2,1-2H3;2-4,9-12H,5-8H2,1H3;6-8,11H,3-5H2,1-2H3.
What are the key properties of N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine?
N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine has a molecular weight of 1402.50 g/mol, XLogP of 11.48, 15 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(2-fluorophenyl)methyl]acetamide;N-cyclopropyl-2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N-[(4-fluorophenyl)methyl]acetamide;3-[1-[5-(1,1-difluoroethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyrrolidin-2-yl]-5-methyl-1,2-oxazole;7-methyl-5-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-[1,2,4]triazolo[1,5-a]pyridine is sourced from PubChem (CID 161307572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).